Triple Therapy Halves Exacerbations In Moderate-to-severe COPD, Study Suggests
Thursday, October 8, 2009 - 08:14
in Health & Medicine
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting beta-agonist, an inhaled corticosteroid and an anti-muscarinic agent, according to researchers.